POS1268 PHASE II TRIAL OF ENPATORAN IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

J. E. Mckinnon; J. Santiaguel; C. Murta; D. Yu; M. Khursheed; F. Moreau; L. Klopp-Schulze; J. Shaw; S. Roy; A. Kao

doi:10.1136/annrheumdis-2022-eular.4528

Article info

PDF

Scientific Abstracts

POSTERS only

COVID-19

POS1268 PHASE II TRIAL OF ENPATORAN IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

Free

Authors

J. E. Mckinnon Henry Ford Hospital, Department of Medicine, Detroit, United States of America PubMed articles Google scholar articles
J. Santiaguel Quirino Memorial Medical Center, Internal Medicine, Quezon City, Philippines PubMed articles Google scholar articles
C. Murta Santa Casa de Misericórdia, Ambulatório de Pesquisa Clínica, Belo Horizonte, Brazil PubMed articles Google scholar articles
D. Yu EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Global Clinical Development, Billerica, United States of America PubMed articles Google scholar articles
M. Khursheed Merck Serono Ltd., an affiliate of Merck KGaA, Global Patient Safety, Feltham, United Kingdom PubMed articles Google scholar articles
F. Moreau EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, Global Biostatistics, Billerica, United States of America PubMed articles Google scholar articles
L. Klopp-Schulze Merck Healthcare KGaA, Translational Medicine, Darmstadt, Germany PubMed articles Google scholar articles
J. Shaw EMD Serono, an affiliate of Merck KGaA, Translational Medicine, Billerica, United States of America PubMed articles Google scholar articles
S. Roy Ares Trading SA, an affiliate of Merck KGaA, Global Clinical Development, Eysins, Switzerland PubMed articles Google scholar articles
A. Kao EMD Serono Research & Development Institute, Inc., an affiliate of Merck KGaA, TIP Immunology, Billerica, United States of America PubMed articles Google scholar articles

Citation

Mckinnon JE, Santiaguel J, Murta C, et al

POS1268 PHASE II TRIAL OF ENPATORAN IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA

Annals of the Rheumatic Diseases 2022;81:971-972.

Publication history

First published May 23, 2022.

Online issue publication

May 23, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password